TrialThe Lancet. Infectious diseases2023

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.

Ephraim L Tsalik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.